Agios Pharmaceuticals (AGIO) Tax Rate (2012 - 2025)
Agios Pharmaceuticals' (AGIO) quarterly Tax Rate came in at 0.93% in Q4 2025, down 749.0% YoY from 0.14% in Q4 2024, and down 88.94% on a QoQ basis from 8.42% in Q4 2024.
Powered by 
Analysis
Agios Pharmaceuticals (AGIO) Tax Rate (2012 - 2025) Analysis & Trends
Agios Pharmaceuticals (AGIO) has 5 years of Tax Rate data on file, last reported at 0.93% in Q4 2025.
- Quarterly Tax Rate fell 749.0% year-over-year to 0.93% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 9.48% (down 1591.0% YoY) and the FY2025 annual result came in at 0.25%, down 592.0% from the prior year.
- Tax Rate fell to 0.93% in Q4 2025, from 8.42% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 8.42% in Q4 2024 to a low of 0.93% in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | -10.89% |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | -1.96% |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | 24.15% |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 7.49% |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | - |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | -16.71% |
| 10 | Agios Pharmaceuticals | 1.97 Bn | 1.97 Bn | 41.75 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 0.93% |
| Dec 31, 2024 | 8.42% |
| Sep 30, 2024 | 5.31% |
| Dec 31, 2014 | -0.08% |
| Sep 30, 2014 | -13.76% |
| Dec 31, 2013 | 30.07% |
| Sep 30, 2013 | -1.09% |
| Jun 30, 2013 | -1.16% |
| Mar 31, 2013 | -2.70% |
| Dec 31, 2012 | 47.68% |
| Sep 30, 2012 | 37.75% |
| Jun 30, 2012 | 38.90% |